Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Roche
Roche
Pfizer's Braftovi to command 42% share of BRAF inhibitors melanoma market by 2028
Biopharma Reporter
Thu, 03/21/24 - 11:37 am
Pfizer
Braftovi
Roche
Zelboraf
melanoma
BMS racks up phase III win in liver cancer targeted by AstraZeneca and Roche
BioSpace
Wed, 03/20/24 - 11:51 am
Bristol Myers Squibb
immuno-oncology
Opdivo
Yervoy
liver cancer
AstraZeneca
Roche
Lonza adds biologics capacity with $1.2bn Roche deal
Pharmaphorum
Wed, 03/20/24 - 11:17 am
Roche
Lonza
drug manufacturing
Switzerland
CDMOs
Roche Plots Neuro Comeback with Promising Mid-Stage Alzheimer’s Data
BioSpace
Tue, 03/12/24 - 11:14 am
Roche
Alzheimer's disease
monoclonal antibodies
Roche to take on Abbott, Dexcom with its first CGM
Medtech Dive
Fri, 03/8/24 - 11:13 am
Medtech
Roche
CGMs
diabetes
Abbott Labs
DexCom
Accu-Chek Smartguide
Asthma Drug Xolair Now Indicated For Food Allergies: Next Challenge Is Insurer Coverage
Forbes
Wed, 03/6/24 - 11:25 am
Roche
Novartis
Xolair
insurers
food allergies
Roche, Alnylam say blood pressure drug succeeds in mid-stage trial
Reuters
Tue, 03/5/24 - 11:07 am
Roche
Alnylam Pharmaceuticals
clinical trials
hypertension
zilebesiran
Roche Reassesses Esbriet's Future Amidst Generic Drug Competition
Medriva
Tue, 02/27/24 - 11:28 am
Roche
generics
Esbriet
IPF
Roche evaluates options for its lung disease drug
Reuters
Mon, 02/26/24 - 05:12 pm
Roche
Esbriet
lung cancer
6 first-half 2024 oncology data readouts to watch
BioSpace
Mon, 02/26/24 - 11:20 am
oncology
clinical trials
Daiichi Sankyo
AstraZeneca
Enhertu
metastatic breast cancer
Gilead Sciences
Trodelvy
bladder cancer
GSK
Zejula
Jemperli
ovarian cancer
Roche
tiragolumab
Tecentriq
non-small cell lung cancer
Cue Biopharma
CUE-101
head and neck cancer
Elicio Therapeutics
ELI-002
solid tumors
Roche's Xolair reduces reactions to severe food allergies in study
Reuters
Sun, 02/25/24 - 05:36 pm
Roche
Novartis
Xolair
clinical trials
food allergies
What did Big Pharma CEOs get paid in 2023?
Medical Marketing and Media
Fri, 02/23/24 - 10:22 am
Pharma CEOs
executive pay
AstraZeneca
Roche
Novartis
After Roche breakup, Blueprint Medicines finds Gavreto a new home at Rigel
Fierce Pharma
Thu, 02/22/24 - 11:40 am
Rigel Pharmaceuticals
Gavreto
RET inhibitors
Blueprint Medicines
Roche
FDA approves Roche, Novartis' Xolair to prevent severe outcomes from common food allergies
Fierce Pharma
Sun, 02/18/24 - 08:31 pm
Roche
Novartis
Xolair
food allergies
FDA
Roche-Backed Freenome Continues Industry’s Funding Rally with $254M Raise
BioSpace
Thu, 02/15/24 - 11:16 am
Freenome
multiomics
Roche
cancer
diagnostics
funding
Roche dumps Repare's synthetic lethal drug days after making $40M stitch in Tapistry trial
Fierce Biotech
Tue, 02/13/24 - 11:29 am
Roche
Repare Therapeutics
solid tumors
clinical trials
synthetic lethality
Roche to shrink product development team, mainly impacting contractors
Fierce Biotech
Fri, 02/9/24 - 11:10 am
Roche
drug development
layoffs
contractors
Roche gets first world okay for PNH drug crovalimab
Pharmaphorum
Thu, 02/8/24 - 10:58 am
Roche
China
crovalimab
PNH
Novartis CEO's 2023 pay rises 21% as Roche's helmsman nets $11M in his first year
Fierce Pharma
Mon, 02/5/24 - 11:16 pm
Novartis
Roche
Pharma CEOs
executive pay
Vas Narasimhan
Thomas Schinecker
Roche shares fall on modest 2024 outlook
Reuters
Thu, 02/1/24 - 11:16 am
Roche
earnings
Pages
« first
‹ previous
…
2
3
4
5
6
7
8
9
10
…
next ›
last »